Two tyramine-derived amides (compounds 4 and 5) are the promising compounds in the future of the anti-diabetes treatment, since they could strongly inhibit the activity from the alpha-glucosidase and their mode of inhibition (an uncompetitive manner) provided a superior for drug development in the animal model compared with the other modes of inhibition. The gene discussed is GAA; the disease is diabetes mellitus.